Leukaemia, the most common cancer in children, is becoming less frequent worldwide. A major global study shows that between 1990 and 2021, childhood leukaemia rates steadily declined—bringing real progress in the fight against this disease.
New individualized cancer treatments are emerging, with the potential to revolutionize how patients receive care.
A new treatment for patients with heart failure reduces deaths by 62 percent and is currently being rolled out in various hospitals around the world.
